UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 691

Sortiert nach

A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis

PloS one, 2022, Vol.17 (5), p.e0267183-e0267183

2022

Volltextzugriff (PDF)

ILB ® Attenuates Clinical Symptoms and Serum Biomarkers of Oxidative/Nitrosative Stress and Mitochondrial Dysfunction in Patients with Amyotrophic Lateral Sclerosis

Journal of personalized medicine, 2021-08, Vol.11 (8), p.794

2021

Volltextzugriff (PDF)

Linking phenological shifts to species interactions through size-mediated priority effects

The Journal of animal ecology, 2014-09, Vol.83 (5), p.1206-1215

2014

Volltextzugriff (PDF)

Differences in quality of life modalities give rise to needs of individual support in patients with ALS and their next of kin

Palliative & supportive care, 2010-03, Vol.8 (1), p.75-82

2010

Volltextzugriff (PDF)

Population and Community Ecology of Ontogenetic Development

2013

Volltextzugriff (PDF)

Correlations in health status between estimates of families of people with amyotrophic lateral sclerosis and estimates of staff

Palliative & supportive care, 2013-06, Vol.11 (3), p.183-189

2013

Volltextzugriff (PDF)

Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer’s disease

Neurochemistry international, 2004-07, Vol.45 (1), p.57-62

2004

Volltextzugriff (PDF)

Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) : Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Trial

Stroke (1970), 2008-11, Vol.39 (11), p.3015-3021

2008

Volltextzugriff (PDF)

A phase II open label clinical study of the safety, tolerability and efficacy of ILB.sup.® for Amyotrophic Lateral Sclerosis

PloS one, 2022-05, Vol.17 (5), p.e0267183

2022

Volltextzugriff (PDF)

Tätare uppdateringar behövs av riktlinjer vid astma och KOL

Läkartidningen, 2020, Vol.117

Larsson, Kjell

2020

Volltextzugriff (PDF)

A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis

PloS one, 2022-01, Vol.17 (5)

2022

Volltextzugriff (PDF)

Fatigue and Peripheral Muscle Dysfunction: Studies on Vitamin D Status, Muscle Metabolism and Systemic Inflammation in Patients With COPD Aspects of COPD Severity Beyond FEV1 and Exacerbations

Kentson, Magnus

2022

Volltextzugriff (PDF)

Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time

Acta neurologica Scandinavica, 2010-04, Vol.121 (4), p.244-250

2010

Volltextzugriff (PDF)

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

Journal of neurochemistry, 1996-11, Vol.67 (5), p.2013-2018

1996

Volltextzugriff (PDF)

A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters

Acta neurologica Scandinavica, 2003-07, Vol.108 (1), p.1-8

2003

Volltextzugriff (PDF)

Blood-brain barrier dysfunction to peroxidase after air embolism, aggravated by acute ethanol intoxication

Journal of the neurological sciences, 1979-06, Vol.42 (1), p.65-72

1979

Volltextzugriff (PDF)

Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin

Epilepsy research, 1992-03, Vol.11 (1), p.45-49

1992

Volltextzugriff (PDF)

Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures

Epilepsy research, 1995-07, Vol.21 (3), p.231-236

1995

Volltextzugriff (PDF)

Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine

Epilepsy research, 1990-07, Vol.6 (2), p.134-140

1990

Volltextzugriff (PDF)

Cellular composition of primary cultures from cerebral cortex, striatum, hippocampus, brainstem and cerebellum

Brain research, 1984-05, Vol.300 (1), p.9-18

1984

Volltextzugriff (PDF)

Effect of Long-Term Vigabatrin Therapy on Selected Neurotransmitter Concentrations in Cerebrospinal Fluid

Journal of child neurology, 1991-10, Vol.6 (2_suppl), p.2S11-2S16

1991

Volltextzugriff (PDF)

Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy

Epilepsy research, 1988-03, Vol.2 (2), p.96-101

1988

Volltextzugriff (PDF)

Effect of radiologic contrast media and local anaesthetics on the blood-brain barrier and on the leptomeninges

Acta neurologica Scandinavica, 1992-06, Vol.85 (S138), p.164-170

1992

Volltextzugriff (PDF)

Brain primary culture — a characterization

Brain research, 1980-04, Vol.188 (1), p.233-246

1980

Volltextzugriff (PDF)

Cytotoxicity of an antiserum to an acidic protein present in mesodermal macrophages

Immunology letters, 1979, Vol.1 (1), p.49-51

1979

Volltextzugriff (PDF)

1 – 25 von 691

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(578)
Mit Volltextzugriff
(606)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(472)
Life Sciences & Biomedicine
(426)
Biological And Medical Sciences
(252)
Humans
(226)
Male
(152)
Animals
(148)
Medical Sciences
(143)
Ecology
(142)
Female
(134)
Environmental Sciences & Ecology
(132)
Fundamental And Applied Biological Sciences. Psychology
(118)
Medicin Och Hälsovetenskap
(116)
Adult
(103)
Medical And Health Sciences
(89)
Animal, Plant And Microbial Ecology
(86)
Animal And Plant Ecology
(83)
Middle Aged
(83)
Aged
(67)
Neurosciences & Neurology
(67)
Klinisk Medicin
(65)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis

ILB ® Attenuates Clinical Symptoms and Serum Biomarkers of Oxidative/Nitrosative Stress and Mitochondrial Dysfunction in Patients with Amyotrophic Lateral Sclerosis

Linking phenological shifts to species interactions through size-mediated priority effects

Differences in quality of life modalities give rise to needs of individual support in patients with ALS and their next of kin

Population and Community Ecology of Ontogenetic Development

Correlations in health status between estimates of families of people with amyotrophic lateral sclerosis and estimates of staff

Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer’s disease

Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) : Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Trial

A phase II open label clinical study of the safety, tolerability and efficacy of ILB.sup.® for Amyotrophic Lateral Sclerosis

Tätare uppdateringar behövs av riktlinjer vid astma och KOL

A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis

Fatigue and Peripheral Muscle Dysfunction: Studies on Vitamin D Status, Muscle Metabolism and Systemic Inflammation in Patients With COPD Aspects of COPD Severity Beyond FEV1 and Exacerbations

Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters

Blood-brain barrier dysfunction to peroxidase after air embolism, aggravated by acute ethanol intoxication

Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin

Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures

Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine

Cellular composition of primary cultures from cerebral cortex, striatum, hippocampus, brainstem and cerebellum

Effect of Long-Term Vigabatrin Therapy on Selected Neurotransmitter Concentrations in Cerebrospinal Fluid

Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy

Effect of radiologic contrast media and local anaesthetics on the blood-brain barrier and on the leptomeninges

Brain primary culture — a characterization

Cytotoxicity of an antiserum to an acidic protein present in mesodermal macrophages

Suchergebnisse filtern